Cargando…
A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
Recent reports state that the prevalence of tardive dyskinesia (TD) is 32% with typical antipsychotics, and 13% with atypical antipsychotics. Current evidence-based recommendations determine an unmet need for efficacious treatment of TD. This systematic review was planned to update the evidence for...
Autores principales: | Patel, Rikinkumar S., Mansuri, Zeeshan, Motiwala, Fatima, Saeed, Hina, Jannareddy, Namrata, Patel, Hiren, Zafar, Muhammad Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535739/ https://www.ncbi.nlm.nih.gov/pubmed/31205680 http://dx.doi.org/10.1177/2045125319847882 |
Ejemplares similares
-
The effects of valbenazine on tardive dyskinesia in older and younger patients
por: Sajatovic, Martha, et al.
Publicado: (2019) -
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019) -
Analysis of risk factors and outcomes in psychiatric inpatients with tardive dyskinesia: A nationwide case-control study
por: Patel, Rikinkumar S., et al.
Publicado: (2019) -
Successful Treatment of Severe Tardive Dyskinesia with Valbenazine, Including a Patient’s Perspective
por: Josiassen, Richard C., et al.
Publicado: (2017) -
Use of Valbenazine in a 54-Year-Old Female with Severe Tardive Dyskinesia
por: Yee, Maria Ruiza, et al.
Publicado: (2020)